TuisRPGLIFE ⢠NSE
add
RPG Life Sciences Limited
Vorige sluiting
ā¹2Ā 174,50
Dagwisseling
ā¹2Ā 105,00 - ā¹2Ā 235,00
Jaarwisseling
ā¹1Ā 381,00 - ā¹2Ā 974,95
Markkapitalisasie
35,06Ā mjd INR
Gemiddelde volume
24,09Ā k
P/V-verhouding
44,31
Dividend-opbrengs
0,75%
PrimĆŖre beurs
NSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(INR) | Des. 2024info | J/J-verandering |
---|---|---|
Inkomste | 1,73Ā mjd | 12,37% |
Bedryfskoste | 729,00Ā m | 1,57% |
Netto inkomste | 349,30Ā m | 32,01% |
Netto winsgrens | 20,22 | 17,42% |
Wins per aandeel | ā | ā |
EBITDA | 477,15Ā m | 28,14% |
Effektiewe belastingkoers | 25,51% | ā |
Balansstaat
Totale bates
Totale aanspreeklikheid
(INR) | Des. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 1,26Ā mjd | 23,53% |
Totale bates | ā | ā |
Totale aanspreeklikheid | ā | ā |
Totale ekwiteit | 3,79Ā mjd | ā |
Uitstaande aandele | 16,54Ā m | ā |
Prys om te bespreek | 9,48 | ā |
Opbrengs op bates | ā | ā |
Opbrengs op kapitaal | 28,80% | ā |
Kontantvloei
Netto kontantverandering
(INR) | Des. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 349,30Ā m | 32,01% |
Kontant van bedrywe | ā | ā |
Kontant van beleggings | ā | ā |
Kontant van finansiering | ā | ā |
Netto kontantverandering | ā | ā |
Beskikbare kontantvloei | ā | ā |
Meer oor
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
Gestig
1993
Webwerf
Werknemers
1Ā 270